C. Soler
Impact in
- Microbiology top 2%
- Microbial infections and disease research
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 21
- Mycobacterium research and diagnosis 15
-
- Tuberculosis Research and Epidemiology 13
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- P. Jault (3 shared papers)Thomas Leclerc (2 shared papers)Jérôme Gabard (2 shared papers)Yok‐Ai Que (1 shared paper)Serge Jennes (1 shared paper)Hervé Carsin (1 shared paper)Ronan Le Floch (1 shared paper)Laurent Bretaudeau (1 shared paper)
- Journals
- PLoS ONE (2 papers)Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The International Journal of Tuberculosis and Lung Disease (2 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- FranceDjiboutiUnited States
In The Last Decade
C. Soler
41 papers receiving 1.3k citations
C. Soler's Hit Papers
Peers
Comparison fields: 5 of 88
- Microbiology 255
- Molecular Medicine 194
- Infectious Diseases 467
- Ecology 595
- Microbiology 16
Countries citing papers authored by C. Soler
This map shows the geographic impact of C. Soler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Soler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Soler more than expected).
Fields of papers citing papers by C. Soler
This network shows the impact of papers produced by C. Soler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Soler. The network helps show where C. Soler may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Soler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial Hit paper breakdown → | 2018 | 663 |
| 2 | 2012 | 87 | |
| 3 | 2010 | 59 | |
| 4 | 2014 | 53 | |
| 5 | 2018 | 51 | |
| 6 | 2012 | 46 | |
| 7 | 2015 | 43 | |
| 8 | 2016 | 34 | |
| 9 | 2010 | 30 | |
| 10 | 2017 | 29 | |
| 11 | 2011 | 29 | |
| 12 | 2013 | 27 | |
| 13 | 2009 | 26 | |
| 14 | 2012 | 20 | |
| 15 | 2011 | 17 | |
| 16 | 2021 | 13 | |
| 17 | 1999 | 13 | |
| 18 | 2011 | 10 | |
| 19 | 2014 | 7 | |
| 20 | 2019 | 6 |
About C. Soler
C. Soler is a scholar working on Epidemiology, Infectious Diseases, Surgery, Molecular Medicine and Molecular Biology, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (15 papers), Tuberculosis Research and Epidemiology (13 papers), Antibiotic Resistance in Bacteria (7 papers), Diagnosis and treatment of tuberculosis (5 papers), Infectious Diseases and Tuberculosis (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Bacteriophages and microbial interactions (3 papers). The work is most often cited by research in Microbiology (255 citations), Molecular Medicine (194 citations), Infectious Diseases (467 citations), Ecology (595 citations) and Microbiology (16 citations). C. Soler has collaborated with scholars based in France, Djibouti and United States. Frequent co-authors include P. Jault, Thomas Leclerc, Jérôme Gabard, Yok‐Ai Que, Serge Jennes, Hervé Carsin, Ronan Le Floch, Laurent Bretaudeau, François Ravat and Jean‐Paul Pirnay. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, The International Journal of Tuberculosis and Lung Disease and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.